Michael House, MD
Surgery · Indianapolis, INNPI 1528232451
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,750 of the $2,463 with a category attached, or 71.1%. Sirtex Medical Inc accounts for 71.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,944 and has fallen 87.3% since, to $247 in 2025.
Across 12 payments — averaging $205.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sirtex Medical Inc$2K
- Johnson & Johnson$251
- Dilon Technologies, Inc.$175
- Artivion, Inc.$112
- Medtronic$80
- AstraZeneca$68
- plus $27 from 2 others
What the payments were for
- Speaking & faculty fees$1,75071%
- Food & beverage$64426%
- Education$683%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sirtex Medical Inc | 1 | $1,750 |
| Johnson & Johnson | 4 | $251 |
| Dilon Technologies, Inc. | 1 | $175 |
| Artivion, Inc. | 1 | $112 |
| Medtronic | 2 | $80 |
| AstraZeneca | 1 | $68 |
| Integra Lifesciences Corporation | 1 | $23 |
| Intuitive Surgical | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIR-Spheres Microspheres$1,750
- HemoBlast Bellows$175
- ENSEAL Product Family$117
- VASCULAR$112
How this compares
$2,463 in reported general payments places this provider in the 55th percentile of 524 surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 63 | $153,087 |
| Oxycodone Hcl | 29 | $148 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $145 |
| Pantoprazole Sodium | 29 | $141 |
| Spironolactone | 11 | $108 |
Paid to pharmacies, not to this prescriber.
Other surgery in Indianapolis
- Paul SzotekIndianapolis$2.4M
- Michael MillerIndianapolis$53K
- Marita BaumanIndianapolis$29K
- Rosalie CarrIndianapolis$24K
- Steven MongIndianapolis$22K
- Jonathan MandelbaumIndianapolis$21K
- Jenalee CookseyIndianapolis$19K
- Chandrashekhar KubalIndianapolis$15K
- John PowelsonIndianapolis$14K
- Carlos Gonzalez RendonMunster$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.